Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1945 3
1946 1
1947 5
1948 6
1949 5
1950 10
1951 14
1952 5
1953 14
1954 27
1955 19
1956 19
1957 11
1958 16
1959 28
1960 22
1961 17
1962 20
1963 48
1964 80
1965 48
1966 65
1967 104
1968 103
1969 116
1970 102
1971 120
1972 157
1973 114
1974 115
1975 95
1976 96
1977 94
1978 110
1979 109
1980 116
1981 105
1982 138
1983 158
1984 148
1985 190
1986 172
1987 180
1988 213
1989 259
1990 264
1991 251
1992 285
1993 329
1994 437
1995 469
1996 413
1997 507
1998 559
1999 548
2000 578
2001 586
2002 542
2003 605
2004 707
2005 750
2006 896
2007 918
2008 1102
2009 1361
2010 1605
2011 1848
2012 2179
2013 2368
2014 2673
2015 2969
2016 3056
2017 3343
2018 3479
2019 3769
2020 4046
2021 4577
2022 4469
2023 4304
2024 4514
2025 315

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59,009 results

Results by year

Filters applied: . Clear all
Page 1
Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques.
Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, Kościński J, Graczyk P, Hałas T, Lewandowska AM, Czepczyński R, Ruchała M. Czarnywojtek A, et al. Pharmacology. 2023;108(5):423-431. doi: 10.1159/000531319. Epub 2023 Jul 17. Pharmacology. 2023. PMID: 37459849 Free article. Review.
BACKGROUND: Glioblastoma multiforme (GBM) is a WHO grade 4 glioma and the most common malignant primary brain tumour. ...
BACKGROUND: Glioblastoma multiforme (GBM) is a WHO grade 4 glioma and the most common malignant primary brain tumour. ...
Current Immunotherapies for Glioblastoma Multiforme.
Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H. Huang B, et al. Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020. Front Immunol. 2021. PMID: 33767690 Free PMC article. Review.
Glioblastoma multiforme (GBM) is the most common and aggressive malignant tumor found in the central nervous system. ...
Glioblastoma multiforme (GBM) is the most common and aggressive malignant tumor found in the central nervous system. ...
Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S, Pesee M, Supaadirek C, Supakalin N, Thamronganantasakul K, Krusun S. Witthayanuwat S, et al. Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2613-2617. doi: 10.22034/APJCP.2018.19.9.2613. Asian Pac J Cancer Prev. 2018. PMID: 30256068 Free PMC article.
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological diagnosis of Glioblastoma Multiforme (GBM) between 1 January 1994 and 30 November 2013, were retrospectively reviewed. ...
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological di …
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy.
Kumari S, Gupta R, Ambasta RK, Kumar P. Kumari S, et al. Biochim Biophys Acta Rev Cancer. 2023 Jul;1878(4):188913. doi: 10.1016/j.bbcan.2023.188913. Epub 2023 May 12. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37182666 Review.
Glioblastoma multiforme (GBM) is an aggressive brain cancer showing poor prognosis. Currently, treatment methods of GBM are limited with adverse outcomes and low survival rate. ...
Glioblastoma multiforme (GBM) is an aggressive brain cancer showing poor prognosis. Currently, treatment methods of GBM are li …
Glioblastoma multiforme.
Williams DS. Williams DS. J Insur Med. 2014;44(1):62-4. J Insur Med. 2014. PMID: 25004601
Glioblastoma Multiforme is the most common and most aggressive malignant primary brain tumor in humans....
Glioblastoma Multiforme is the most common and most aggressive malignant primary brain tumor in humans....
Nanoformulations for glioblastoma multiforme: a new hope for treatment.
Ortiz R, Cabeza L, Perazzoli G, Jimenez-Lopez J, García-Pinel B, Melguizo C, Prados J. Ortiz R, et al. Future Med Chem. 2019 Sep;11(18):2459-2480. doi: 10.4155/fmc-2018-0521. Epub 2019 Sep 23. Future Med Chem. 2019. PMID: 31544490 Review.
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults, associated with a high mortality rate and a survival of between 12 and 15 months after diagnosis. ...
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults, associated with a high mortality rat …
Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion.
Helson L, Majeed M. Helson L, et al. Anticancer Res. 2019 Jul;39(7):3423-3427. doi: 10.21873/anticanres.13487. Anticancer Res. 2019. PMID: 31262865 Review.
Current clinical failure to cure primary glioblastoma multiforme in virtually all adult patients is due to genetic aberrations, molecular heterogeneity, and clonal evolution of tumor stem and differentiated cells within the core tumor, leading to their migration, in …
Current clinical failure to cure primary glioblastoma multiforme in virtually all adult patients is due to genetic aberrations …
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme.
Kumari S, Gupta R, Ambasta RK, Kumar P. Kumari S, et al. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188999. doi: 10.1016/j.bbcan.2023.188999. Epub 2023 Oct 18. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37858622 Review.
Recent multi-omics studies, including proteomics, transcriptomics, genomics, and metabolomics have revealed the critical role of post-translational modifications (PTMs) in the progression and pathogenesis of Glioblastoma multiforme (GBM). Further, PTMs alter the onc …
Recent multi-omics studies, including proteomics, transcriptomics, genomics, and metabolomics have revealed the critical role of post-transl …
Extra Neural Metastasis Of Glioblastoma Multiforme: A Literature Review.
Shoaib F, Furrukh M, Mushtaq F, Sayeed S, Nasir H, Ghafoor H. Shoaib F, et al. J Pak Med Assoc. 2023 Sep;73(9):1869-1873. doi: 10.47391/JPMA.7694. J Pak Med Assoc. 2023. PMID: 37817700 Free article. Review.
Extra-neural metastases of glioblastoma multiforme are uncommon with unidentified metastatic mechanism. There is no consensus over optimum treatment regimen. ...
Extra-neural metastases of glioblastoma multiforme are uncommon with unidentified metastatic mechanism. There is no consensus …
Reactive Astrocytes in Glioblastoma Multiforme.
Guan X, Hasan MN, Maniar S, Jia W, Sun D. Guan X, et al. Mol Neurobiol. 2018 Aug;55(8):6927-6938. doi: 10.1007/s12035-018-0880-8. Epub 2018 Jan 23. Mol Neurobiol. 2018. PMID: 29363044 Review.
Despite the multidisciplinary integration in the therapeutic management of glioblastoma multiforme (GBM), the prognosis of GBM patients is poor. There is growing recognition that the cells in the tumor microenvironment play a vital role in regulating the progression …
Despite the multidisciplinary integration in the therapeutic management of glioblastoma multiforme (GBM), the prognosis of GBM …
59,009 results
You have reached the last available page of results. Please see the User Guide for more information.